ORLISTAT TEVA
60MG CPS DUR 84 I
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Interruption of marketing | 09.05.2022 | Lék obtížně nahraditelný | Capacity/distribution reasons | 31.07.2022 |
Resumption of marketing | 11.01.2022 | |||
Interruption of marketing | 17.01.2022 |
0157949 |
Capacity/distribution reasons | únor 2022 |
Resumption of marketing | 21.07.2020 | |||
Interruption of marketing | 20.07.2020 |
0157949 |
Manufacturing reasons | 15.08.2020 |
Placing on the market | 11.07.2019 |
All reports are available in the Overview.